SAFETY, EFFICACY AND INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS (PUPS) TREATED EXCLUSIVELY WITH RECOMBINANT B-DOMAIN DELETED F-VIII (RVIII-SQ) - 2.5 STUDY YEARS
Jm. Lusher et J. Spira, SAFETY, EFFICACY AND INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS (PUPS) TREATED EXCLUSIVELY WITH RECOMBINANT B-DOMAIN DELETED F-VIII (RVIII-SQ) - 2.5 STUDY YEARS, Blood, 90(10), 1997, pp. 2664-2664